We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Research Alliance Corporation II | NASDAQ:RACB | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.105 | 9.68 | 13.18 | 0 | 01:00:00 |
|
/s/ Peter Kolchinsky, Ph.D.
Peter Kolchinsky, Ph.D.
Chief Executive Officer and Chairman |
| | | |
|
/s/ Peter Kolchinsky, Ph.D.
Peter Kolchinsky, Ph.D.
Chief Executive Officer and Chairman |
| | | |
| | | | | 2 | | | |
| | | | | 3 | | | |
| | | | | 13 | | | |
| | | | | 18 | | | |
| | | | | 25 | | | |
| | | | | 30 | | | |
| | | | | 31 | | | |
| | | | | 34 | | | |
| | | | | 37 | | |
| | |
Class A Common Stock
|
| |
Class B Common Stock
|
| |
Approximate
Percentage of Outstanding Shares |
| |||||||||||||||||||||
Name of Beneficial Owners(1)
|
| |
Number of
Shares Beneficially Owned |
| |
Approximate
Percentage of Class |
| |
Number of
Shares Beneficially Owned(2) |
| |
Approximate
Percentage of Class |
| ||||||||||||||||||
Research Alliance Holdings II LLC (our sponsor)(2)
|
| | | | 499,000 | | | | | | 3.2% | | | | | | 3,647,500 | | | | | | 97.6% | | | | | | 21.6% | | |
Peter Kolchinsky Ph.D.
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Tess Cameron(2)
|
| | | | 499,000 | | | | | | 3.2% | | | | | | 3,647,500 | | | | | | 97.6% | | | | | | 21.6% | | |
Matthew Hammond Ph.D.
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Stephen J. Hoffman M.D., Ph.D.
|
| | | | — | | | | | | — | | | | | | 30,000 | | | | | | * | | | | | | * | | |
Thomas Leggett
|
| | | | — | | | | | | — | | | | | | 30,000 | | | | | | * | | | | | | * | | |
Clive Patience Ph.D
|
| | | | — | | | | | | — | | | | | | 30,000 | | | | | | * | | | | | | * | | |
All directors and officers as a group (Six individuals)
|
| | | | 499,000 | | | | | | 3.2% | | | | | | 3,737,500 | | | | | | 100.0% | | | | | | 22.1% | | |
Laurion Capital Management LP(3)
|
| | | | 800,000 | | | | | | 5.2% | | | | | | — | | | | | | — | | | | | | 4.2% | | |
Sculptor Capital LP(4)
|
| | | | 789,870 | | | | | | 5.1% | | | | | | — | | | | | | — | | | | | | 4.1% | | |
Citadel Advisors LLC(5)
|
| | | | 941,126 | | | | | | 6.1% | | | | | | — | | | | | | — | | | | | | 4.9% | | |
HealthCor Management, L.P.(6)
|
| | | | 1,324,800 | | | | | | 8.6% | | | | | | — | | | | | | — | | | | | | 6.9% | | |
Alyeska Investment Group, L.P.(7)
|
| | | | 800,000 | | | | | | 5.2% | | | | | | — | | | | | | — | | | | | | 4.2% | | |
Perceptive Advisors LLC(8)
|
| | | | 1,000,000 | | | | | | 6.5% | | | | | | — | | | | | | — | | | | | | 5.2% | | |
Saba Capital Management, L.P.(9)
|
| | | | 1,950,574 | | | | | | 12.6% | | | | | | — | | | | | | — | | | | | | 10.2% | | |
By: |
|
1 Year Research Alliance Corpor... Chart |
1 Month Research Alliance Corpor... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions